vTv Therapeutics Announces Completion of Phase 1b Study Evaluating TTP399 for the Treatment of Type 1 Diabetes Read more
Aldevron Selects AES, Begins Construction of Cleanrooms in $30 Million GMP Plasmid Facility Read more
Invitation from ZivaAbarahm, CEO at Microrite chairing The 2nd Annual Pharmaceutical Microbiology West Coast Conference 2018 Read more